{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:26:24Z","timestamp":1789503984421,"version":"build-2803163510"},"reference-count":55,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Chronic thromboembolic pulmonary disease (CTEPD) and chronic thromboembolic pulmonary hypertension (CTEPH) are debilitating complications of acute pulmonary embolism (PE) that are characterized by fibrosis and organization of the thrombotic material within pulmonary artery branches. This pathology leads to increased right ventricular afterload and dead space ventilation, posing a risk of progressive pulmonary hypertension, right-sided heart failure, and potentially death if left untreated. Pulmonary endarterectomy (PTE) is a technically complex open-heart surgery considered to be a first-line treatment as it is a potentially curative therapy. Although PTE is highly successful in proximal disease, it may not reach the very distal branches. On the other hand, pulmonary vasodilator therapy is very effective in improving microvasculopathy but does not address the obstructive fibrotic component of the larger vessels. Balloon pulmonary angioplasty (BPA) is a novel percutaneous revascularization therapy in which traditional angioplasty techniques are used to relieve obstruction in the pulmonary arteries. This review discusses the currently accepted indications, patient selection, technical considerations, outcomes, and complications of contemporary BPA. This review will address knowledge gaps and future perspectives in BPA research.<\/jats:p>","DOI":"10.3390\/jcm14030699","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:50:53Z","timestamp":1737525053000},"page":"699","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evolution and New Perspectives of Balloon Pulmonary Angioplasty in CTEPH"],"prefix":"10.3390","volume":"14","author":[{"given":"Julia","family":"Larsen","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Diseases, Temple University Hospital, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Lakhter","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Temple University Hospital, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Nasri","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Temple University Hospital, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-3566","authenticated-orcid":false,"given":"Riyaz","family":"Bashir","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, Temple University Hospital, Philadelphia, PA 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_2","unstructured":"Bashir, R., Auger, W.R., and Rosenfield, K. (2024, February 12). \u201cBalloon Pulmonary Angioplasty in CTEPH and CTEPD: Where Is This All Going?\u201d Endovascular Today, Bryn Mawr Communications, 24 January 2024. Available online: https:\/\/evtoday.com\/articles\/2024-jan\/balloon-pulmonary-angioplasty-in-cteph-and-ctepd-where-is-this-all-going."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.jacc.2018.04.009","article-title":"Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable Disease","volume":"71","author":"Mahmud","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wang, J., Liu, J., Tao, X., Xie, W., Wang, S., Zhang, S., Zhang, Z., Fu, Z., Li, H., and Zhang, Y. (2023). Safety and efficacy of balloon pulmonary angioplasty for technically operable chronic thromboembolic pulmonary hypertension. Pulm. Circ., 14.","DOI":"10.1002\/pul2.12327"},{"key":"ref_5","first-page":"637","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"44","author":"Montani","year":"2015","journal-title":"Presse Med."},{"key":"ref_6","first-page":"39","article-title":"Switching from sildenafil to riociguat for the treatment of PAH and inoperable CTEPH: Real-life experiences","volume":"22","author":"Andersen","year":"2017","journal-title":"Respir. Med. Case Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1209657","article-title":"Riociguat for the treatment of chronic thromboembolic pulmonary hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_8","unstructured":"Drugs.com (2024, January 24). Drug Price Information. Available online: https:\/\/www.drugs.com\/price-guide."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1074248419877409","article-title":"Treatment discontinuation or interruption in pulmonary arterial hypertension","volume":"25","author":"Narechania","year":"2020","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jcin.2019.01.237","article-title":"Balloon Pulmonary Angioplasty (Percutaneous Transluminal Pulmonary Angioplasty) for Chronic Thromboembolic Pulmonary Hypertension: A Japanese Perspective","volume":"12","author":"Kataoka","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2008.08.059","article-title":"Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial","volume":"52","author":"Jais","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.healun.2006.12.014","article-title":"Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension","volume":"26","author":"Cabrol","year":"2007","journal-title":"J. Heart Lung Transpl."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/eurheartj\/ehx530","article-title":"Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: Long-term effects and procedure-related complications","volume":"38","author":"Aoki","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lang, I., Meyer, B.C., Ogo, T., Matsubara, H., Kurzyna, M., Ghofrani, H.A., Mayer, E., and Brenot, P. (2017). Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. Eur. Respir. Rev., 26, Erratum in Eur. Respir. Rev. 2017, 26, 165119.","DOI":"10.1183\/16000617.5119-2016"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Inami, T., Kataoka, M., Ando, M., Fukuda, K., Yoshino, H., and Satoh, T. (2014). A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094587"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mahmud, E., Patel, M., Ang, L., and Poch, D. (2021). Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Pulm. Circ., 11.","DOI":"10.1177\/20458940211007385"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jevnikar, M., Bokan, A., Gillem, T., Bertoletti, L., and Lichtblau, M. (2022). Balloon pulmonary angioplasty: Are we there yet? Lessons learned and unanswered questions. Breathe, 18.","DOI":"10.1183\/20734735.0217-2022"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1378\/chest.94.6.1249","article-title":"Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism","volume":"94","author":"Voorburg","year":"1988","journal-title":"Chest."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.CIR.103.1.10","article-title":"Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension","volume":"103","author":"Feinstein","year":"2001","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bashir, R., Noory, A., Oliveros, E., Romero, C., Maruthi, R., Mirza, A., Lakhter, V., Zhao, H., Brisco-Bacik, M., and Vaidya, A. (2023). Refined Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: Initial Results of U.S. Regional Program. JACC Adv., 2.","DOI":"10.1016\/j.jacadv.2023.100291"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCINTERVENTIONS.112.971077","article-title":"Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension","volume":"5","author":"Mizoguchi","year":"2012","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jcin.2014.06.010","article-title":"Pressure-wire-guided percutaneous transluminal pulmonary angioplasty: A breakthrough in catheter-interventional therapy for chronic thromboembolic pulmonary hypertension","volume":"7","author":"Inami","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2967\/jnumed.106.039438","article-title":"Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension","volume":"48","author":"Tunariu","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/thorax-2022-219716","article-title":"Cardiac MRI in the assessment of chronic thromboembolic pulmonary hypertension and response to treatment","volume":"79","author":"Bartnik","year":"2024","journal-title":"Thorax"},{"key":"ref_26","first-page":"E211","article-title":"Optimal Technique for Performing Invasive Pulmonary Angiography for Chronic Thromboembolic Pulmonary Disease","volume":"31","author":"Ang","year":"2019","journal-title":"J. Invasive Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra0910203","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"364","author":"Piazza","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e1090","DOI":"10.1161\/CIR.0000000000001197","article-title":"Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease with and Without Pulmonary Hypertension: A Scientific Statement from the American Heart Association","volume":"149","author":"Aggarwal","year":"2024","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/eurheartj\/ehad413","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: A clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function","volume":"44","author":"Lang","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ogawa, A., and Matsubara, H. (2015). Balloon Pulmonary Angioplasty: A Treatment Option for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension. Front. Cardiovasc. Med., 2.","DOI":"10.3389\/fcvm.2015.00004"},{"key":"ref_31","first-page":"103","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension","volume":"7","author":"Mahmud","year":"2018","journal-title":"Interv. Cardiol. Clin."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Daigo, K., Katsumata, Y., Esaki, K., Iwasawa, Y., Ichihara, G., Miura, K., Shirakawa, K., Sato, Y., Sato, K., and Fukuda, K. (2023). Predictors of Improvement in Exercise Tolerance After Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. J. Am. Heart Assoc., 12.","DOI":"10.1161\/JAHA.122.027395"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000502254","article-title":"Changes in estimated glomerular filtration after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension","volume":"10","author":"Darocha","year":"2020","journal-title":"Cardiorenal Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/00365513.2019.1601765","article-title":"Development of renal function during staged balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension","volume":"79","author":"Kriechbaum","year":"2019","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.115.019470","article-title":"Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: Results from the United Kingdom National Cohort","volume":"133","author":"Cannon","year":"2016","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.115.016522","article-title":"Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry","volume":"133","author":"Delcroix","year":"2016","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Banaszkiewicz, M., Kurzyna, P., Kubikowska, N., Mucha, M., Rudnik, A., G\u0105secka, A., Pietrasik, A., Grabowski, M., Jaguszewski, M.J., and Kasprzyk, P. (2023). Emerging Role of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease-Insights from the 2022 ESC Guidelines. J. Clin. Med., 12.","DOI":"10.3390\/jcm12165336"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.healun.2015.10.030","article-title":"Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension","volume":"35","author":"Wiedenroth","year":"2016","journal-title":"J. Heart. Lung Transpl."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.jacc.2022.01.052","article-title":"Percutaneous Pulmonary Angioplasty for Patients with Takayasu Arteritis and Pulmonary Hypertension","volume":"79","author":"Zhou","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.21037\/cdt.2018.01.04","article-title":"Pulmonary vascular anatomy & anatomical variants","volume":"8","author":"Kandathil","year":"2018","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.21037\/qims.2018.09.08","article-title":"Augmented reality and three-dimensional printing in percutaneous interventions on pulmonary arteries","volume":"9","author":"Witowski","year":"2019","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Li, X., Zhang, Y., Jin, Q., Luo, Q., Zhao, Q., Yang, T., Zeng, Q., Yan, L., Duan, A., and Huang, Z. (2022). Predictors of early response to balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Ther. Adv. Respir. Dis., 16.","DOI":"10.1177\/17534666221138001"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00270-022-03323-8","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: A systematic review and meta-analysis","volume":"46","author":"Kennedy","year":"2023","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ogawa, A., Satoh, T., Fukuda, T., Sugimura, K., Fukumoto, Y., Emoto, N., Yamada, N., Yao, A., Ando, M., and Ogino, H. (2017). Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: Results of a multicenter registry. Circ. Cardiovasc. Qual. Outcomes, 10.","DOI":"10.1161\/CIRCOUTCOMES.117.004029"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Brenot, P., Ja\u00efs, X., Taniguchi, Y., Garcia Alonso, C., Gerardin, B., Mussot, S., Mercier, O., Fabre, D., Parent, F., and Jevnikar, M. (2019). French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Eur. Respir. J., 53.","DOI":"10.1183\/13993003.02095-2018"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Poch, D.S., Mahmud, E., Patel, M., Papamatheakis, D., Fernandes, T., Kerr, K., Yang, J., Pretorius, V., Madani, M.M., and Kim, N.H. (2022). Patient selection for balloon pulmonary angioplasty: Six-year results from a high volume PTE surgical center. Pulm. Circ., 12.","DOI":"10.1002\/pul2.12148"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Carlozzi, L.N., Lee, J., Barros, L.M., Buber, Y., Chen, D.L., Mulligan, M., Ordovas, K., Ralph, D.D., Rayner, S.G., and Leary, P.J. (2023). Establishing a balloon pulmonary angioplasty program for chronic thromboembolic pulmonary hypertension: A United States single-center experience. Respir. Med., 211.","DOI":"10.1016\/j.rmed.2023.107215"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.mayocpiqo.2019.06.006","article-title":"Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: Initial single-center experience","volume":"3","author":"Anand","year":"2019","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Rich, L., Patel, N., Hyder, S.N., Gurm, H., Moles, V., Agarwal, P.P., Visovatti, S., Haft, J., Cascino, T., and Mclaughlin, V.V. (2023). Safe and effective balloon pulmonary angioplasty in the outpatient setting: The Michigan Medicine experience. J. Soc. Cardiovasc. Angiogr. Interv., 2.","DOI":"10.1016\/j.jscai.2023.100589"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"00850","DOI":"10.1183\/23120541.00850-2020","article-title":"Current strategies for managing chronic thromboembolic pulmonary hypertension: Results of the worldwide prospective CTEPH registry","volume":"7","author":"Guth","year":"2021","journal-title":"ERJ Open Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.chest.2021.05.052","article-title":"Results from the United States chronic thromboembolic pulmonary hyperten-sion registry: Enrollment characteristics and 1-year follow-up","volume":"160","author":"Kerr","year":"2021","journal-title":"Chest"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S2213-2600(22)00214-4","article-title":"Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): A multicentre, phase 3, open-label, randomized controlled trial and ancillary follow-up study","volume":"10","author":"Brenot","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-2600(22)00171-0","article-title":"Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): An open-label, randomised controlled trial","volume":"10","author":"Kawakami","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jcin.2013.03.009","article-title":"Pulmonary Edema Predictive Scoring Index (PEPSI), a New Index to Predict Risk of Reperfusion Pulmonary Edema and Improvement of Hemodynamics in Percutaneous Transluminal Pulmonary Angioplasty","volume":"6","author":"Inami","year":"2013","journal-title":"J. Am. Coll. Cardiol. Interv."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Spencer, R., Valencia Villeda, G., Takeda, K., and Rosenzweig, E.B. (2020). Chronic Thromboembolic Pulmonary Hypertension in a Child with Sickle Cell Disease. Front. Pediatr., 8.","DOI":"10.3389\/fped.2020.00363"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/699\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:33:35Z","timestamp":1759919615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jcm14030699"],"URL":"https:\/\/doi.org\/10.3390\/jcm14030699","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]}}}